Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Non-Current Assets

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Assets ₹7,362 Cr₹5,630 Cr₹5,881 Cr₹6,840 Cr₹7,115 Cr

What is the latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS is ₹7,362 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Assets
Mar2026₹7,362 Cr
Mar2025₹5,630 Cr
Mar2024₹5,881 Cr
Mar2023₹6,840 Cr
Mar2022₹7,115 Cr

How is Total Non-Current Assets of GLENMARK PHARMACEUTICALS Trending?

Years Total Non-Current Assets % Change
Mar2026 ₹7,362 Cr
30.76
Mar2025 ₹5,630 Cr
-4.27
Mar2024 ₹5,881 Cr
-14.03
Mar2023 ₹6,840 Cr
-3.86
Mar2022 ₹7,115 Cr -

Compare Total Non-Current Assets of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹69,910.8 Cr 1.1% 7.9% 22.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,339.0 Cr -2.7% -3.7% 20.3% Stock Analytics
DIVIS LABORATORIES ₹254,068.0 Cr 3.7% 15.7% 51% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,767.0 Cr -0.8% 1% 36.2% Stock Analytics
CIPLA ₹111,804.0 Cr -2.1% -5.2% -11.6% Stock Analytics
DR REDDYS LABORATORIES ₹96,113.4 Cr -0.8% -0.5% -9.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.1%

7.9%

22.8%

SENSEX

-1.8%

-3.7%

-5.7%


You may also like the below Video Courses